CalibreScientific Acquires BIOZOL Diagnostica, a Leading Independent Distributor of Life Science Products with Extensive Relationships Across Germany
LOS ANGELES, May 14, 2018 (GLOBE NEWSWIRE) -- CalibreScientific is pleased to announce that it has completed the acquisition of BIOZOL Diagnostica Vertrieb GmbH ("BIOZOL" or the "Company"), an independent distributor of life science products across Germany.
Headquartered just outside of Munich, Germany, BIOZOL is one of the largest independent distributors of life science products with a broad offering that spans a variety of innovative suppliers. Its product portfolio of more than 6 million SKUs includes antibodies, proteins, ELISAs, detection kits, biochemicals, reagents and diagnostics kits. Supported by an employee base with deep scientific knowledge, BIOZOL is able to provide a true consultative approach to meet the growing needs of its broad base of customers. This highly diversified client base includes major universities, private and public research institutions, biotechnology, diagnostics and pharmaceutical companies.
"We are excited to add BIOZOL to the CalibreScientific family as its size and scale in Germany presents actionable growth opportunities for the two companies," said Ben Travis, CEO of CalibreScientific. "BIOZOL has built a great reputation in the marketplace over the last 25+ years and we look forward to continuing on that tradition by adding new innovative suppliers to the portfolio to provide a comprehensive solution set with the goal of becoming a single-source provider for our customers."
"This is an exciting time for all of us," stated BIOZOL's Managing Director, Ralf Bäuerle. "The management team at CalibreScientific shared our vision for driving growth over the coming years and we look forward to leveraging their vast experience in the life sciences industry to help elevate BIOZOL to the next level with the goal of enhancing our capabilities in Germany and beyond."
About CalibreScientific Inc.
CalibreScientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics and biopharmaceutical communities. The Company is committed to pushing the boundaries of science and innovation through internal expertise combined with strategic acquisitions that help deliver a differentiated and comprehensive set of products, services and support to our customers. CalibreScientific represents a portfolio of niche life science companies, across various key verticals, that have an unrivaled ability to address the unique challenges of their respective markets. Through a combination of acquisitions and organic growth our global reach extends into over 53 countries, empowering customers all over the world. Headquartered in Los Angeles, California, CalibreScientific continues to grow across a wide array of verticals and geographies, further diversifying its product offering and global footprint to laboratories around the world.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: CalibreScientific via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
Fujitsu Deploys Juniper Networks' AppFormix for Cloud Operations Management and Optimization22.5.2018 04:00 | Pressmeddelande
AppFormix features such as real-time intelligent monitoring and the easy visualization of data, were crucial for the increased requirements of the new region of Fujitsu's K5 cloud platform TOKYO, May 22, 2018 (GLOBE NEWSWIRE) -- Juniper Networks (NYSE:JNPR), an industry leader in automated, scalable and secure networks, today announced that Fujitsu Limited has deployed Juniper's cloud management platform AppFormix in Japan, as a key part of ensuring the operational efficiency of the new region of its widely adopted enterprise cloud platform Cloud Service K5. Open, agile and legacy-compatible, Fujitsu's K5 is the world's largest open-source based platform and has seen strong adoption globally by organizations looking to drive digital business transformation, across the public, private and hybrid cloud. However, the open-source software used previously for the management of the K5 platform did not provide Fujitsu with the automated real-time management and data visualization features it
Fentress Architects: The Future of Airports as Civic Spaces21.5.2018 22:27 | Pressmeddelande
The European Cultural Centre and Global Art Affairs Foundation invited Fentress Architects and North Carolina State University College of Design to participate in the 2018 Venice Architecture Biennale May 26-November 25, 2018, at the historic Palazzo Bembo. Denver, Colo. - May 21, 2018, May 21, 2018 (GLOBE NEWSWIRE) -- Architecture students from North Carolina State University College of Design will join Fentress at the Palazzo Bembo to present their designs for airports of the future. Fentress has been guiding students in preparation for the exhibition, which allows 11 students to embark on a once-in-a-lifetime opportunity to travel to Italy for the 2018 Venice Biennale of Architecture. Their designs will be featured in the "Time Space Existence" exhibit, offering the public a glimpse at the future of airport design. The students are participating in an Airport Design course with Principal in Charge of Design Curt Fentress, FAIA, RIBA, and Alumni Distinguished Professor of Architectur
Oxford Immunotec's T-SPOT®.TB Test Included in the World Health Organization's First-Ever Essential Diagnostics List21.5.2018 22:15 | Pressmeddelande
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 21, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that the Company's T-SPOT.TB test for tuberculosis (TB) infection has been included in the World Health Organization (WHO) Model List of Essential In Vitro Diagnostics (EDL) - First Edition. The EDL includes the 113 most important tests recommended by WHO for use at various levels of the health care system. These essential diagnostics satisfy the priority health care needs of the population and were selected with due regard to disease prevalence and public health relevance, evidence of efficacy and accuracy, and comparative cost-effectiveness. 58 of the tests listed are for the detection and diagnosis of a wide range of common conditions, providing an essential package that can form the basis for screening and management of patients. The remaining 55 tests are designed for the detection, diagnosis, and moni
Virgin Pulse and RedBrick Health Joining Forces to Create World's Largest Digital Employee Wellbeing and Engagement Company21.5.2018 17:00 | Pressmeddelande
Merger Will Create First and Only One-Stop-Shop for Employee Health, Wellbeing and Benefits Engagement; Combined Company Will Have More Than 3,300 Customers Across 190 Countries PROVIDENCE, R.I., May 21, 2018 (GLOBE NEWSWIRE) -- Providence-based Virgin Pulse and Minneapolis-based RedBrick Health announced today that the industry pioneers will merge, creating the world's largest, most comprehensive digital health and engagement company. This powerful combination will deliver the industry's only fully integrated digital platform, with benefits navigation and live coaching to support global clients and members across the entire health, wellbeing and benefits lifecycle - from screening and assessment to activation, behavior change and the adoption of sustainable, healthy habits. "We are thrilled to join with RedBrick to set a new vision and standard for employee health, wellbeing and engagement," said David Osborne, Virgin Pulse CEO, who will serve as CEO of the combined company. "Bringing
Hotels.com App Wins 2018 MediaPost Appy Award in Travel & Tourism Category21.5.2018 16:00 | Pressmeddelande
Developed by EPAM, app is recognized for creativity and excellence in app design NEWTOWN, Pa., May 21, 2018 (GLOBE NEWSWIRE) -- Hotels.com® and EPAM Systems, Inc. (NYSE:EPAM) announced their triumphant win at the 2018 MediaPost Appy Awards in the Travel and Tourism category this week. The Hotels.com mobile app, developed in collaboration with EPAM Systems, Inc., a leading global provider of digital platform engineering and software development services, has been crowned the best app developed for airlines, hotels, travel search engines, destinations, cruises, travel advice or car rentals. With over 70 million downloads and a 4.5+ star rating from consumers on both iOS and Android app stores, the Hotels.com app has now been recognized by the industry leading Appy Awards, which honor creativity and excellence in app design. The app provides a simple, fast and secure way for users to plan, book and manage hotel reservations, and allows travelers to book hundreds of thousands of places to
Karolinska Development's portfolio company Pharmanest appoints new CEO21.5.2018 15:01 | Pressmeddelande
STOCKHOLM, May 21, 2018. Karolinska Development's portfolio company Pharmanest AB announces the appointment of Helena Jansson as new Chief Executive Officer. Helena is an experienced life science executive, with a proven track record of successful business development and commercialization of pharmaceutical products. She replaces Gunilla Lundmark, who leaves her position after seven years. Helena Jansson has long experience in the life science industry and a broad knowledge base with a focus on business development and commercialization of pharmaceutical portfolios. She has spent a substantial part of her career at Medivir AB, in positions such as Business Unit Director, Head of Supply Chain and Director Alliance Management. In 2017, Pharmanest signed an outlicensing agreement with Gedeon Richter, a leading European pharmaceutical company within women's health. The agreement gives Gedeon Richter the marketing and sales rights to commercialize Pharmanest's first product SHACT (Short Act
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum